Year-end Sale % OFF 
Abstract
Introduction/BackgroundDifferentiation of benign and malignant ovarian tumors before surgery is difficult with currently used biomarker based algorithms such as the Risk of Malignancy Index (RMI), and these algorithms are prone...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
